These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7624960)

  • 41. IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.
    Roychowdhury S; Blaser BW; Freud AG; Katz K; Bhatt D; Ferketich AK; Bergdall V; Kusewitt D; Baiocchi RA; Caligiuri MA
    Blood; 2005 Oct; 106(7):2433-5. PubMed ID: 15976176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine-tuning the EBV+ hu-PBL-SCID xenogeneic chimera model using in vivo superinfection.
    Kvell K; Balogh P; Németh P
    Pathol Oncol Res; 2000; 6(4):280-6. PubMed ID: 11173661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
    Banti S; Miller PJ; Parker CD; Ananth SL; Horn LL; Babu YS; Sandhu JS
    Int Immunopharmacol; 2002 Jun; 2(7):913-23. PubMed ID: 12188033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Vitro Th17-Polarized Human CD4
    Delens L; Ehx G; Somja J; Vrancken L; Belle L; Seidel L; Grégoire C; Fransolet G; Ritacco C; Hannon M; Dubois S; Beguin Y; Baron F; Servais S
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):204-215. PubMed ID: 30326279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engraftment of human peripheral blood lymphocytes in normal strains of mice.
    Lubin I; Segall H; Marcus H; David M; Kulova L; Steinitz M; Erlich P; Gan J; Reisner Y
    Blood; 1994 Apr; 83(8):2368-81. PubMed ID: 8161804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
    van Rijn RS; Simonetti ER; Hagenbeek A; Hogenes MC; de Weger RA; Canninga-van Dijk MR; Weijer K; Spits H; Storm G; van Bloois L; Rijkers G; Martens AC; Ebeling SB
    Blood; 2003 Oct; 102(7):2522-31. PubMed ID: 12791667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes.
    Lazarus AH; Crow AR; Semple JW; Cosgrave D; Kalovsky EJ; Hannach B; Blanchette V; Freedman J
    Transfusion; 1997; 37(11-12):1192-9. PubMed ID: 9426645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An in vivo model of human skin acute graft-versus-host disease: transplantation of cultured human epidermal cells and dermal fibroblasts with human lymphocytes into SCID mice.
    Takakura I; Yabe M; Kato Y; Matsumoto M; Yabe H; Inokuchi S; Kidokoro M; Takakura I; Shimamura K; Kato S
    Exp Hematol; 1999 Dec; 27(12):1815-21. PubMed ID: 10641599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Itacitinib prevents xenogeneic GVHD in humanized mice.
    Courtois J; Ritacco C; Dubois S; Canti L; Vandenhove B; Seidel L; Daulne C; Caers J; Servais S; Beguin Y; Ehx G; Baron F
    Bone Marrow Transplant; 2021 Nov; 56(11):2672-2681. PubMed ID: 34172892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The SCID mouse model: a discussion.
    Weetman AP
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():40-2. PubMed ID: 8986421
    [No Abstract]   [Full Text] [Related]  

  • 51. Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells.
    Garcia S; Dadaglio G; Gougeon ML
    Blood; 1997 Jan; 89(1):329-36. PubMed ID: 8978309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spontaneous xenogeneic GvHD in Wilms' tumor Patient-Derived xenograft models and potential solutions.
    Monzavi SM; Muhammadnejad A; Behfar M; Khorsand AA; Muhammadnejad S; Kajbafzadeh AM
    Animal Model Exp Med; 2022 Dec; 5(4):389-396. PubMed ID: 35726155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model.
    Pirruccello SJ; Nakamine H; Beisel KW; Kleveland KL; Okano M; Taguchi Y; Davis JR; Mahloch ML; Purtilo DT
    Am J Pathol; 1992 May; 140(5):1187-94. PubMed ID: 1580330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.
    Taylor PC
    Int J Exp Pathol; 1992 Apr; 73(2):251-9. PubMed ID: 1571284
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of immune memory of human lymphocytes engrafted in SCID mice.
    Peled A; Leykin I; Deckmann M; Shinitzky M
    Immunobiology; 1999 Sep; 201(1):145-50. PubMed ID: 10532287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of a heterologous, cutaneous graft-versus-host reaction in mice. II. Reactivity of graft and host].
    Brune K; Bucher KE
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(2):73-86. PubMed ID: 4400329
    [No Abstract]   [Full Text] [Related]  

  • 57. Angiogenesis induction by xenogeneic lymphoid and non-lymphoid cells in mice.
    Kamiński MJ; Bem W; Majewski S; Kamińska G; Szmurło A
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):521-3. PubMed ID: 6174103
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells.
    Morrissey PJ; Charrier K
    Res Immunol; 1994 Jun; 145(5):357-62. PubMed ID: 7701115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engraftment of tonsillar mononuclear cells in human skin/SCID mouse chimera--validation of a novel xenogeneic transplantation model for autoimmune diseases.
    Yamanaka N; Yamamoto Y; Kuki K
    Microbiol Immunol; 2001; 45(7):507-14. PubMed ID: 11529556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The SCID-hu xenogeneic transplantation model: complex but telling.
    Boehncke WH
    Arch Dermatol Res; 1999; 291(7-8):367-73. PubMed ID: 10482004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.